0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Reducing High Blood Cholesterol Levels With Drugs-Reply

Kevin A. Shulman, MD; Bruce Kinosian, MD; Terry A. Jacobson, MD; Henry Glick, MA; John M. Eisenberg, MD; Harris Koffer, PharmD; Mary Kaye Willian, DrPH, RN
JAMA. 1991;265(15):1950. doi:10.1001/jama.1991.03460150053015.
Text Size: A A A
Published online

In Reply. —  Drs Bentkover, Boselli, and Lambird raise several issues concerning our article; the principal ones concern our construction of the LDL-HDL index, our analytic perspective, and the costs of side effects. We address these in turn.Dr Bentkover correctly observes that the LDL-HDL index reported in Table 1 (p 3028) does not appear well calibrated; it finds gemfibrozil ( —16) to be almost equivalent to cholestyramine resin ( —14), yet the two long-term trials for these agents indicate substantially different reductions in CHD risk (34% vs 19%). Dr Boselli also faults our first index, arguing that Gordon's1 observations indicate that elevations of HDL cholesterol levels and diminutions of LDL cholesterol levels have equivalent effects on CHD risk.Neither author notes that we report on a second index in our sensitivity analysis. This index is better calibrated with the long-term trials (gemfibrozil, —15.5; cholestyramine resin, —10.9) and equates the effects

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();